Studies of the hepatotrophic qualities of FK 506 and CyA
about
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfallsCurrent status of FK 506 in liver transplantation.FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats.The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats.FK 506 modulates D-galactosamine-induced hepatitis in rats.Protective effect of FK 506 against hepatic ischemia in rats.
P2860
Studies of the hepatotrophic qualities of FK 506 and CyA
description
1990 nî lūn-bûn
@nan
1990 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Studies of the hepatotrophic qualities of FK 506 and CyA
@ast
Studies of the hepatotrophic qualities of FK 506 and CyA
@en
Studies of the hepatotrophic qualities of FK 506 and CyA
@nl
type
label
Studies of the hepatotrophic qualities of FK 506 and CyA
@ast
Studies of the hepatotrophic qualities of FK 506 and CyA
@en
Studies of the hepatotrophic qualities of FK 506 and CyA
@nl
prefLabel
Studies of the hepatotrophic qualities of FK 506 and CyA
@ast
Studies of the hepatotrophic qualities of FK 506 and CyA
@en
Studies of the hepatotrophic qualities of FK 506 and CyA
@nl
P2093
P2860
P1476
Studies of the hepatotrophic qualities of FK 506 and CyA
@en
P2093
A Francavilla
C L Scotti-Foglieni
G Carrieri
J Trejo Bellido
K A Porter
V Mazzaferro
P2860
P407
P577
1990-02-01T00:00:00Z